HK Stock Market Move | WEIMOB INC(02013) rose more than 6% and will release mid-term financial results tomorrow. The company is actively promoting the integration of AI technology with its core business.
Weimob Group (02013) rose more than 6%, as of the time of writing, it rose 6.59% to 2.75 Hong Kong dollars, with a trading volume of 4.44 billion Hong Kong dollars.
WEIMOB INC (02013) surged more than 6%, rising to 6.59% as of the time of writing, reaching 2.75 Hong Kong dollars, with a trading volume of 4.44 billion Hong Kong dollars.
On the news front, WEIMOB INC will hold a board meeting on August 20 (this Wednesday) to consider and approve the company and its subsidiaries' mid-term performance until June 30, 2025, and their release. A research report by FIRST SHANGHAI previously pointed out that the group is actively promoting the integration of AI technology with core business, and Weimob WAI has accessed more than 10 large model platforms including DeepSeek and Tencent Mix Element, and has deployed a matrix of 15 AIAgent products for industries such as e-commerce and retail. The adoption rates of AI-generated copy and images have increased by 53.4% and 13.4% respectively compared to the same period last year. With the upgrading of residents' consumption willingness and the normalization of enterprise operations in the future, the advertising business will gradually pick up, and the bank expects the company to see a business recovery in 2025.
Related Articles

NT Pharma (01011) will be temporarily suspended from trading starting from the afternoon of August 19th.

ONEWO (02602) will distribute an interim dividend of HKD 0.951 per share on September 26th.
GEELY AUTO (00175) issued a total of 75,500 shares due to the exercise of subscription rights.
NT Pharma (01011) will be temporarily suspended from trading starting from the afternoon of August 19th.

ONEWO (02602) will distribute an interim dividend of HKD 0.951 per share on September 26th.

GEELY AUTO (00175) issued a total of 75,500 shares due to the exercise of subscription rights.
RECOMMEND

Former Innovative Pharma Star Faces Growing Pains—Why Zai Lab’s Stock Tumbled Despite Strong Results
18/08/2025

World Humanoid Robot Games In-Depth: Competition Drives Technological Innovation and Accelerates Industry Progress
18/08/2025

Guangdong Cross-Border E-Commerce: Tariff Pressures Spur Overseas Warehouse Boom as Sellers Target Russia and Latin America
18/08/2025